142 related articles for article (PubMed ID: 30968527)
1. Basal cell carcinomas treated with 0.5% 5-fluorouracil and 10% salicylic acid topical solution.
Diluvio L; Lanna C; Lozzi F; Palumbo V; Bianchi L; Campione E
Dermatol Ther; 2019 May; 32(3):e12908. PubMed ID: 30968527
[TBL] [Abstract][Full Text] [Related]
2. Dermoscopic monitoring of efficacy of ingenol mebutate in the treatment of pigmented and non-pigmented basal cell carcinomas.
Diluvio L; Bavetta M; Di Prete M; Orlandi A; Bianchi L; Campione E
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27860083
[TBL] [Abstract][Full Text] [Related]
3. A prospective randomized exploratory study comparing the efficacy of once-daily topical 0.5% 5-fluorouracil in combination with 10.0% salicylic acid (5-FU/SA) vs. cryosurgery for the treatment of hyperkeratotic actinic keratosis.
Simon JC; Dominicus R; Karl L; Rodríguez R; Willers C; Dirschka T
J Eur Acad Dermatol Venereol; 2015 May; 29(5):881-9. PubMed ID: 25257941
[TBL] [Abstract][Full Text] [Related]
4. Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Love WE; Bernhard JD; Bordeaux JS
Arch Dermatol; 2009 Dec; 145(12):1431-8. PubMed ID: 20026854
[TBL] [Abstract][Full Text] [Related]
5. Fluorouracil paste treatment of thin basal cell carcinomas.
Epstein E
Arch Dermatol; 1985 Feb; 121(2):207-13. PubMed ID: 3977335
[TBL] [Abstract][Full Text] [Related]
6. Peculiar clinical and dermoscopic remission pattern following imiquimod therapy of basal cell carcinoma in seborrhoeic areas of the face.
Diluvio L; Campione E; Paternò EJ; Orlandi A; Terrinoni A; Chimenti S
J Dermatolog Treat; 2009; 20(2):124-9. PubMed ID: 18991155
[TBL] [Abstract][Full Text] [Related]
7. Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma.
Mohs FE; Jones DL; Bloom RF
Arch Dermatol; 1978 Jul; 114(7):1021-2. PubMed ID: 686718
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
9. Low-Dose 0.5% 5-Fluorouracil/10% Salicylic Acid Topical Solution in the Treatment of Actinic Keratoses.
Herranz P; Morton C; Dirschka T; Azeredo RR; Roldán-Marín R
J Cutan Med Surg; 2016 Nov; 20(6):555-561. PubMed ID: 27443886
[TBL] [Abstract][Full Text] [Related]
10. Topical 5% 5-fluorouracil in the treatment of multifocal basal cell carcinoma of the face: A novel chemotherapeutic approach.
Naik MP; Mehta A; Abrol S; Kumar S; Gupta VS
Orbit; 2016 Dec; 35(6):352-354. PubMed ID: 27715359
[TBL] [Abstract][Full Text] [Related]
11. Actikerall™ (5-Fluorouracil 0.5% and Salicylic Acid 10%) Topical Solution for Patient-directed Treatment of Actinic Keratoses.
Nguyen HP; Rivers JK
Skin Therapy Lett; 2016 May; 21(3):1-3. PubMed ID: 27223248
[TBL] [Abstract][Full Text] [Related]
12. 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction.
Gross K; Kircik L; Kricorian G
Dermatol Surg; 2007 Apr; 33(4):433-9; discussion 440. PubMed ID: 17430377
[TBL] [Abstract][Full Text] [Related]
13. Use of reflectance confocal microscopy to evaluate 5-fluorouracil 0.5%/salicylic acid 10% in the field-directed treatment of subclinical lesions of actinic keratosis: subanalysis of a Phase III, randomized, double-blind, vehicle-controlled trial.
Ulrich M; Reinhold U; Falqués M; Rodriguez Azeredo R; Stockfleth E
J Eur Acad Dermatol Venereol; 2018 Mar; 32(3):390-396. PubMed ID: 28960520
[TBL] [Abstract][Full Text] [Related]
14. In vivo reflectance confocal microscopy characterization of field-directed 5-fluorouracil 0.5%/salicylic acid 10% in actinic keratosis.
Ulrich M; Alarcon I; Malvehy J; Puig S
Dermatology; 2015; 230(3):193-8. PubMed ID: 25721522
[TBL] [Abstract][Full Text] [Related]
15. Treatment monitoring of 5-fluorouracil 0.5%/salicylic acid 10% lesion-directed therapy for actinic keratosis using dermoscopy and in-vivo reflectance confocal microscopy.
Pampena R; Condorelli A; Cornacchia L; Guiducci L; Raucci M; Benati E; Mirra M; Peris K; Lai M; Pellacani G; Longo C
Dermatol Ther; 2020 Jul; 33(4):e13744. PubMed ID: 32478958
[TBL] [Abstract][Full Text] [Related]
16. Topical therapy in the treatment of actinic keratosis and basal cell carcinoma.
Newman MD; Weinberg JM
Cutis; 2007 Apr; 79(4 Suppl):18-28. PubMed ID: 17508492
[TBL] [Abstract][Full Text] [Related]
17. The invisible basal cell carcinoma: how reflectance confocal microscopy improves the diagnostic accuracy of clinically unclear facial macules and papules.
Ruini C; Hartmann D; Saral S; Krammer S; Ruzicka T; von Braunmühl T
Lasers Med Sci; 2016 Nov; 31(8):1727-1732. PubMed ID: 27492373
[TBL] [Abstract][Full Text] [Related]
18. Successful treatment of multiple superficial basal cell carcinomas with topical imiquimod: case report and review of the literature.
Drehs MM; Cook-Bolden F; Tanzi EL; Weinberg JM
Dermatol Surg; 2002 May; 28(5):427-9. PubMed ID: 12030878
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of Keratinocyte Carcinomas and Patients with Keratinocyte Carcinomas Following a Single 2-4 Week Course of Topical 5-fluorouracil on the Face and Ears.
Beatson M; Means AD; Leader NF; Robinson-Bostom L; Weinstock MA
Acta Derm Venereol; 2019 Jun; 99(7):707-708. PubMed ID: 30896781
[No Abstract] [Full Text] [Related]
20. Successful treatment of multifocal pigmented basal cell carcinomas with the application of topical 5% imiquimod cream.
Plachouri KM; Balasis S; Mallioris AF; Koumoundourou D; Georgiou S
Dermatol Ther; 2018 Sep; 31(5):e12685. PubMed ID: 30133929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
